Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (1,783,966)	$ (161)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	757,545
Amortization of debt issuance costs	83,647
Equity in loss of unconsolidated investment		161
Unrealized foreign currency adjustment	(149,278)
Changes in operating assets and liabilities:
Other assets, net	(208,781)
Accounts payable and accrued liabilities	498,532
Due to affiliates	89,354
Net cash used in operating activities	(712,947)
Cash flows from investing activities:
Purchase of real estate	(39,241,028)
Additions to real estate facilities	(108,099)
Investments in unconsolidated real estate ventures	(177,946)
Net cash used in investing activities	(39,527,073)
Cash flows from financing activities:
Gross proceeds from issuance of common stock	52,344,661	51,000
Offering costs	(4,584,234)	(1,000)
Distributions paid to common stockholders	(404,558)
Distributions paid to noncontrolling interest in our Operating Partnership	(67,845)
Net cash provided by financing activities	47,288,024	50,000
Net change in cash, cash equivalents and restricted cash	7,048,004	50,000
Cash, cash equivalents and restricted cash, beginning of year	4,580,759
Cash, cash equivalents and restricted cash, end of period	11,628,763	50,000
Supplemental disclosures and non-cash transactions:
Cash paid for interest	369,541
Real estate facilities in due to affiliates	1,200,000
Proceeds from issuance of common stock in accounts payable and accrued liabilities	(85,000)
Offering costs included in accounts payable and accrued liabilities	263,795	49,994
Issuance of shares pursuant to distribution reinvestment plan	268,630
Distributions payable to common stockholders	421,192	$ 15
Distributions payable to noncontrolling interests in our Operating Partnership	$ 23,365